En Es
Categories

ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is a global provider of in vitro diagnostics, including testing platforms and clinical assay tests to monitor disease progression across multiple disease categories such as infectious diseases, cardiology and endocrinology. It also offers laboratory systems and blood typing products in immunohematolog ...
Products Covid-19NewsSummary
Close

Covid-19 ORTHO CLINICAL DIAGNOSTICS

Clinical Laboratory

Anti-SARS-CoV-2 IgG QN Antibody Assay
VITROS Anti-SARS-CoV-2 IgG QN Antibody Assay

The VITROS Anti-SARS-CoV-2 IgG QN Antibody assay is intended for the qualitative detection and quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma and is processed on Ortho's trusted VITROS system. With 100% specificity and excellent sensitivity, the assay provides numerical values traceable to the World Health Organization (WHO) International Standard, which helps standardize SARS-CoV-2 serological methods and allows for unified data comparison across laboratories.
More details

Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test
VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test

The VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test is a highly accurate4 test for the qualitative detection of SARS-CoV-2 nucleocapsid antibodies in patients who have been infected with the SARS-CoV-2 virus. The test helps health care teams differentiate the cause of antibodies against SARS-CoV-2 and is processed on Ortho's VITROS Systems.
More details

SARS-CoV-2 Antigen Test
VITROS SARS-CoV-2 Antigen Test

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing. Results are reported as either reactive (positive) or non-reactive (negative) with no gray zone, providing healthcare systems and communities more capacity to quickly and accurately diagnose individuals with an active infection. The VITROS SARS-CoV-2 Antigen Test is fully compatible with Ortho’s VITROS XT 7600 and 5600 Integrated Systems and VITROS 3600 Immunodiagnostic System.
More details

SARS-CoV-2 (COVID-19) Antibody Test
40) VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack detects antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus. The test can be used in epidemiological research to help better understand the spread of the disease and can also be used to aid in the diagnosis of suspected COVID-19 patients in conjunction with molecular tests. The test will run on Ortho’s flagship analyzer, the VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, the VITROS 5600 Integrated System and VITROS ECi/ECiQ Immunodiagnostic Systems and can process approximately 150 tests in an hour. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and has also received CE Mark.
More details

SARS-CoV-2 (COVID-19) Antibody Test
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test is a COVID-19 IgG antibody test that detects the IgG antibody and offers 100% specificity. It offers greater choice in tracking and surveillance, patient management, and screening convalescent plasma. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and runs on Ortho's high-throughput, fully automated analyzers including its flagship VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, and the VITROS 5600 Integrated System.
More details
Close

News of ORTHO CLINICAL DIAGNOSTICS

Ortho and Thermo Fisher Enter Into Partnership for Quality Control Products

08 Jul 2021
Ortho and Thermo Fisher Enter Into Partnership for Quality Control Products
Ortho Clinical Diagnostics (Raritan, NJ, USA) has entered into a distribution agreement with Thermo Fisher Scientific Inc. (Waltham, MA, USA) to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's VITROS QC Solutions to VITROS System customers worldwide.
Read More

Ortho Clinical Diagnostics presenta avances cardíacos en EuroMedLab 2019

28 May 2019
Ortho Clinical Diagnostics presenta avances cardíacos en EuroMedLab 2019
Ortho Clinical Diagnostics (Raritan, NJ, EUA) patrocinó un taller educativo sobre los ensayos de troponina de alta sensibilidad y presentó cinco pósteres científicos en EuroMedLab 2019, durante el 23º Congreso Europeo de Química Clínica y Medicina de Laboratorio IFCC-EFLM, que se realizó del 19 al 23 de mayo de 2019 en el CCIB -Centro de Convenciones Internacional de Barcelona. Ortho también mostró sus nuevas láminas de productos químicos VITROS, la Celda VITROS, una solución de automatización compacta que permite que dos instrumentos VITROS XT 7600 (lanzados en 2018) funcionen como una solución perfecta, y el Sistema Integrado VITROS XT 7600 en su stand durante el Congreso. 
Read More

Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019

20 May 2019
Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019
Ortho Clinical Diagnostics sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona.
Read More

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More
Close

About ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is a global provider of in vitro diagnostics, including testing platforms and clinical assay tests to monitor disease progression across multiple disease categories such as infectious diseases, cardiology and endocrinology. It also offers laboratory systems and blood typing products in immunohematology to hospitals, hospital networks, blood banks, and labs around the world.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 Antigen Test

SARS-CoV-2 Antigen Test

Model: VITROS SARS-CoV-2 Antigen Test
Request Information

Description:

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing.
Read More

Full Description Features

Description

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing. Results are reported as either reactive (positive) or non-reactive (negative) with no gray zone, providing healthcare systems and communities more capacity to quickly and accurately diagnose individuals with an active infection. The VITROS SARS-CoV-2 Antigen Test is fully compatible with Ortho’s VITROS XT 7600 and 5600 Integrated Systems and VITROS 3600 Immunodiagnostic System. Request Information

Features

• Rule in/rule out SARS-CoV-2 infection in patients entering the emergency department with the ability to run up to 130 tests per hour on a VITROS Immunodiagnostic or VITROS® Integrated System
• VITROS SARS-CoV-2 Antigen Test can be run alongside other in-vitro diagnostic tests needed for routine testing or for patient management
• Random access testing means a patient sample can be loaded to the VITROS® System at any time
• STAT sample option can be selected
• Simple sample preparation for swabs placed in a viral transport medium Request Information

Send A Message To This Supplier

* Required Information
* Email
To
ORTHO CLINICAL DIAGNOSTICS (SARS-CoV-2 Antigen Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions